Announcements Trials

Browse Landscape

Phase

Phase NA 1 Phase EARLY_PHASE1 1 Phase 4 1 Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Venous Thromboembolism 6 Venous Thrombosis 5 Neoplasms 5 Pulmonary Embolism 4 Neoplasm Metastasis 2 Intracranial Thrombosis 2 Thrombosis 1 Thromboprophylaxis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasms, Plasma Cell 1 Mesenteric Ischemia 1 Lymphoma 1 Hematologic Neoplasms 1

Interventions

Injections 2 enoxaparin sodium 1 bemiparin 1 apixaban 1 Phlebotomy 1 Hydroxyurea 1 Heparin 1 Dalteparin 1 Clopidogrel 1 Aspirin 1 Anticoagulants 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Thrombosis × apixaban × Clear all

NCT03692065 2025-02-06

API-CAT

Assistance Publique - Hôpitaux de Paris

Phase 3 Completed

Neoplasms, Thrombosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡